Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$105,000.00

Evaluation of the cholinergic effect of induced pluripotent stem cell (iPSC) derived parasympathetic neurons as an adjunct in alleviating xerostomia in Sjogren's syndrome.

EF 2021-22

Résumé
Sjogren's syndrome (SS) is a longstanding, progressive disease that is predominant in women and primarily involves decreased bodily fluid secretions. Lack of saliva and its associated symptoms, such as dry mouth, impaired speech, tooth decay, loss of taste, painful inability to swallow, ulcerations and infections in the mouth, ultimately lead to poor quality of life. Dry mouth in SS is known to occur due to improper regulation of the body's immune mechanisms. However, recent findings highlight the possible role of altered or reduced nerve supply to the salivary glands, which leads to decreased saliva production. The current treatment for dry mouth is palliative and aims at symptoms of the patient, as an attempt to improve the quality of life. Symptomatic therapy provided by the use of topical lubricating agents and immunosuppressive drugs have shown improvement; however, they are palliative and associated with a plethora of adverse effects. Moreover, these drugs fail to repair and restore the glandular secretory function. Despite scientific advances, a significant and permanent treatment for dry mouth is yet to be established. Stem cells are specialised human cells that can be used to replace cells that have been damaged or lost due to disease. Recently, stem cells and their applications in the treatment of dry mouth related to oral cancer and SS have proven powerful and promising. Thus, we propose the use of specialised stem cells to regenerate nervous stimulation in the salivary glands, ultimately increasing salivary secretions. Dry mouth can also be due to other health conditions, such as diabetes, stroke, oral fungal infection, Alzheimer's disease, and other autoimmune diseases, such as HIV/AIDS. The results of our studies could pave the way and create a new strategy for innovative uses of stem cells in other conditions leading to dry mouth; thereby solving major problems occurring due to low salivary secretions for millions of patients worldwide.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
458820
Name
Iyer Janaki S
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Evaluation of the cholinergic effect of induced pluripotent stem cell (iPSC) derived parasympathetic neurons as an adjunct in alleviating xerostomia in Sjogren's syndrome.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Induced Pluripotent Stem Cell; Salivary Gland Regeneration; Sjogren'S Syndrome; Stem Cell Therapy; Xerostomia
Abstract
Sjogren's syndrome (SS) is a longstanding, progressive disease that is predominant in women and primarily involves decreased bodily fluid secretions. Lack of saliva and its associated symptoms, such as dry mouth, impaired speech, tooth decay, loss of taste, painful inability to swallow, ulcerations and infections in the mouth, ultimately lead to poor quality of life. Dry mouth in SS is known to occur due to improper regulation of the body's immune mechanisms. However, recent findings highlight the possible role of altered or reduced nerve supply to the salivary glands, which leads to decreased saliva production. The current treatment for dry mouth is palliative and aims at symptoms of the patient, as an attempt to improve the quality of life. Symptomatic therapy provided by the use of topical lubricating agents and immunosuppressive drugs have shown improvement; however, they are palliative and associated with a plethora of adverse effects. Moreover, these drugs fail to repair and restore the glandular secretory function. Despite scientific advances, a significant and permanent treatment for dry mouth is yet to be established. Stem cells are specialised human cells that can be used to replace cells that have been damaged or lost due to disease. Recently, stem cells and their applications in the treatment of dry mouth related to oral cancer and SS have proven powerful and promising. Thus, we propose the use of specialised stem cells to regenerate nervous stimulation in the salivary glands, ultimately increasing salivary secretions. Dry mouth can also be due to other health conditions, such as diabetes, stroke, oral fungal infection, Alzheimer's disease, and other autoimmune diseases, such as HIV/AIDS. The results of our studies could pave the way and create a new strategy for innovative uses of stem cells in other conditions leading to dry mouth; thereby solving major problems occurring due to low salivary secretions for millions of patients worldwide.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Iyer, Janaki S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~